221 related articles for article (PubMed ID: 30565153)
1. What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.
Sommet A; Bénévent J; Rousseau V; Chebane L; Douros A; Montastruc JL; Montastruc F
J Gen Intern Med; 2019 Apr; 34(4):502-503. PubMed ID: 30565153
[No Abstract] [Full Text] [Related]
2. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.
Son N; Choi E; Chung SY; Han SY; Kim B
BMC Cardiovasc Disord; 2022 Feb; 22(1):44. PubMed ID: 35152888
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Pulz S
Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):514-5. PubMed ID: 27631440
[No Abstract] [Full Text] [Related]
4. The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis.
Wee I; Chin B; Syn N; Lee KS; Ng JJ; Choong AMTL
Sci Rep; 2021 May; 11(1):11073. PubMed ID: 34040146
[TBL] [Abstract][Full Text] [Related]
5. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
[TBL] [Abstract][Full Text] [Related]
6. Concerns About Fluoroquinolones and Aortic Aneurysm.
Aschenbrenner DS
Am J Nurs; 2021 May; 121(5):24. PubMed ID: 33872257
[TBL] [Abstract][Full Text] [Related]
7. [Serious side effects of fluoroquinolones: low risk of connective tissue-related disorders such as aneurysms].
Boes J; Dofferhoff ASM; Fleuren HWHA; Kramers C
Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33332024
[TBL] [Abstract][Full Text] [Related]
8. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
[TBL] [Abstract][Full Text] [Related]
9. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
Jun C; Fang B
BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
[TBL] [Abstract][Full Text] [Related]
10. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
[TBL] [Abstract][Full Text] [Related]
11. Relationship between fluoroquinolones and the risk of aortic diseases: a meta-analysis of observational studies.
Dai XC; Yang XX; Ma L; Tang GM; Pan YY; Hu HL
BMC Cardiovasc Disord; 2020 Feb; 20(1):49. PubMed ID: 32013928
[TBL] [Abstract][Full Text] [Related]
12. Fluoroquinolones and the risk of aortopathy: A systematic review and meta-analysis.
Noman AT; Qazi AH; Alqasrawi M; Ayinde H; Tleyjeh IM; Lindower P; Bin Abdulhak AA
Int J Cardiol; 2019 Jan; 274():299-302. PubMed ID: 30309682
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis.
Rawla P; El Helou ML; Vellipuram AR
Cardiovasc Hematol Agents Med Chem; 2019; 17(1):3-10. PubMed ID: 30947680
[TBL] [Abstract][Full Text] [Related]
14. Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis.
Singh S; Nautiyal A
Am J Med; 2017 Dec; 130(12):1449-1457.e9. PubMed ID: 28739200
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.
Latif A; Ahsan MJ; Kapoor V; Lateef N; Malik SU; Patel AD; Khan BA; Bittner M; Holmberg M
WMJ; 2020 Sep; 119(3):185-189. PubMed ID: 33091293
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolones and the risk of aortic aneurysm or aortic dissection: an updated systematic review and meta-analysis including 53,651,283 patients.
Fatima K; Uzair SU; Salman A; Jawed A; Husain MA; Shah MG; Hasnain MA; Jawed A; Vohra LI; Lal PM
Minerva Cardiol Angiol; 2023 Oct; 71(5):485-493. PubMed ID: 36468763
[TBL] [Abstract][Full Text] [Related]
17. Risks associated with the use of fluoroquinolones.
DeLaney MC
Br J Hosp Med (Lond); 2018 Oct; 79(10):552-555. PubMed ID: 30290736
[TBL] [Abstract][Full Text] [Related]
18. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
[TBL] [Abstract][Full Text] [Related]
19. Fluoroquinolones and Risk of Aortic Aneurysm or Dissection in Patients With Congenital Aortic Disease and Marfan Syndrome.
Chen SW; Lin CP; Chan YH; Wu VC; Cheng YT; Tung YC; Hsiao FC; Chen DY; Hung KC; Chou AH; Chu PH
Circ J; 2023 Aug; 87(9):1164-1172. PubMed ID: 36823078
[TBL] [Abstract][Full Text] [Related]
20. Oral Fluoroquinolone and the Risk of Aortic Dissection.
Lee CC; Lee MG; Hsieh R; Porta L; Lee WC; Lee SH; Chang SS
J Am Coll Cardiol; 2018 Sep; 72(12):1369-1378. PubMed ID: 30213330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
